🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Paul Tudor Jones’s MRK Holdings & Trades

First Buy
Q2 2013
Duration Held
47 Quarters
Largest Add
Q3 2025
+787,366 Shares
Current Position
422,770 Shares
$61.43 M Value

Paul Tudor Jones's MRK Position Overview

Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 422,770 shares of Merck & Co., Inc. (MRK) worth $61.43 M, representing 0.08% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 47 quarters.

Based on 13F filings since 2013, Paul Tudor Jones has maintained a long-term strategic position in MRK, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2025, adding 787,366 shares. Largest reduction occurred in Q4 2025, reducing 787,366 shares.

Analysis based on 13F filings available since 2013 Q2

Paul Tudor Jones's Merck & Co (MRK) Holding Value Over Time

Track share changes against reported price movement

Quarterly Merck & Co (MRK) Trades by Paul Tudor Jones

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +422,770 New Buy 422,770 $145.31
Q4 2025 -787,366 Sold Out 0 $0.00
Q3 2025 +787,366 New Buy 787,366 $83.93
Q2 2025 -774,203 Sold Out 0 $0.00
Q1 2025 +723,375 Add 1423.18% 774,203 $89.76
Q4 2024 -117,676 Reduce 69.84% 50,828 $99.48
Q3 2024 +125,129 Add 288.48% 168,504 $113.56
Q2 2024 +43,375 New Buy 43,375 $123.80
Q4 2023 -84,792 Sold Out 0 $0.00
Q3 2023 +84,792 New Buy 84,792 $102.95
Q2 2023 -39,331 Sold Out 0 $0.00
Q1 2023 +39,331 New Buy 39,331 $0.11
Q4 2022 -9,243 Sold Out 0 $0.00
Q3 2022 +9,243 New Buy 9,243 $86.12
Q2 2022 -4,619 Sold Out 0 $0.00
Q1 2022 -39,080 Reduce 89.43% 4,619 $82.05
Q4 2021 +43,699 New Buy 43,699 $76.64
Q3 2021 -15,544 Sold Out 0 $0.00
Q2 2021 +15,544 New Buy 15,544 $77.78
Q1 2021 -27,381 Sold Out 0 $0.00
Q4 2020 +14,833 Add 118.21% 27,381 $78.05
Q3 2020 -47,502 Reduce 79.10% 12,548 $79.14
Q2 2020 +31,315 Add 108.98% 60,050 $73.79
Q1 2020 -61,130 Reduce 68.02% 28,735 $73.43
Q4 2019 +89,865 New Buy 89,865 $86.79
Q3 2019 -9,165 Sold Out 0 $0.00
Q2 2019 +9,165 New Buy 9,165 $79.98
Q2 2018 -67,064 Sold Out 0 $0.00
Q1 2018 +48,417 Add 259.65% 67,064 $51.98
Q4 2017 +18,647 New Buy 18,647 $53.68
Q3 2017 -9,369 Sold Out 0 $0.00
Q2 2017 -167,247 Reduce 94.70% 9,369 $61.16
Q1 2017 +166,241 Add 1602.32% 176,616 $60.63
Q4 2016 -631,839 Reduce 98.38% 10,375 $56.19
Q3 2016 +638,127 Add 15613.58% 642,214 $59.55
Q2 2016 -744,636 Reduce 99.45% 4,087 $55.05
Q1 2016 +706,215 Add 1661.37% 748,723 $50.49
Q4 2015 -4,299 Reduce 9.18% 42,508 $50.39
Q3 2015 +29,096 Add 164.28% 46,807 $47.13
Q2 2015 -84,042 Reduce 82.59% 17,711 $54.32
Q1 2015 +46,129 Add 82.93% 101,753 $54.85
Q4 2014 +22,376 Add 67.30% 55,624 $54.19
Q3 2014 +19,345 Add 139.14% 33,248 $56.57
Q2 2014 +8,626 Add 163.46% 13,903 $55.17
Q1 2014 +5,277 New Buy 5,277 $54.20
Q3 2013 -480,089 Sold Out 0 $0.00
Q2 2013 +480,089 Add 0.00% 480,089 $44.32

Paul Tudor Jones's Merck & Co Investment FAQs

Paul Tudor Jones first purchased Merck & Co., Inc. (MRK) in Q2 2013, acquiring 480,089 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Paul Tudor Jones has held Merck & Co., Inc. (MRK) for 47 quarters since Q2 2013.

Paul Tudor Jones's largest addition to Merck & Co., Inc. (MRK) was in Q3 2025, adding 787,366 shares worth $66.08 M.

According to the latest 13F filing for Q3 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 422,770 shares of Merck & Co., Inc. (MRK), valued at approximately $61.43 M.

As of the Q3 2026 filing, Merck & Co., Inc. (MRK) represents approximately 0.08% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.

Paul Tudor Jones's peak holding in Merck & Co., Inc. (MRK) was 787,366 shares, as reported at the end of Q3 2025.